Aspen Pharmacare Debt to Equity Ratio 2017-2023 | APNHY
Current and historical debt to equity ratio values for Aspen Pharmacare (APNHY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Aspen Pharmacare debt/equity for the three months ending June 30, 2023 was 0.00.
| Aspen Pharmacare Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2023-06-30 |
$2.71B |
$4.86B |
0.56 |
| 2022-12-31 |
$2.58B |
$4.27B |
0.60 |
| 2022-06-30 |
$2.66B |
$4.67B |
0.57 |
| 2021-12-31 |
$2.95B |
$4.68B |
0.63 |
| 2021-06-30 |
$2.87B |
$4.28B |
0.67 |
| 2020-12-31 |
$3.71B |
$4.26B |
0.87 |
| 2020-06-30 |
$4.12B |
$4.46B |
0.92 |
| 2019-06-30 |
$4.80B |
$3.82B |
1.26 |
| 2018-12-31 |
$5.77B |
$3.66B |
1.58 |
| 2018-06-30 |
$6.46B |
$3.91B |
1.65 |
| 2017-12-31 |
$5.75B |
$3.26B |
1.77 |
| 2017-06-30 |
$5.38B |
$3.17B |
1.70 |
| 2016-12-31 |
$4.92B |
$2.84B |
1.73 |
| 2016-06-30 |
$4.29B |
$2.95B |
1.45 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$4.900B |
$2.296B |
|
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|
